Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions

Hans Bisgaard; David Skoner; Maria L Boza; Carol A Tozzi; Kathleen Newcomb; Theodore F Reiss; Barbara Knorr; Gertrude Noonan

doi:10.1002/ppul.21018

Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions

Hans Bisgaard, David Skoner, Maria L Boza, Carol A Tozzi, Kathleen Newcomb, Theodore F Reiss, Barbara Knorr, Gertrude Noonan

Allergi, Hud- og Kønssygdomme

73 Citationer (Scopus)

Abstract

Montelukast is a potent leukotriene-receptor antagonist administered once daily that provides clinical benefit in the treatment of asthma and allergic rhinitis in children and adults. Because of its wide use as a pediatric controller, there is a need for a further review of the safety and tolerability of montelukast in children.

Originalsprog	Engelsk
Tidsskrift	Pediatric Pulmonology
Vol/bind	44
Udgave nummer	6
Sider (fra-til)	568-79
Antal sider	12
ISSN	8755-6863
DOI	https://doi.org/10.1002/ppul.21018
Status	Udgivet - 1 jun. 2009

Adgang til dokumentet

10.1002/ppul.21018

Citationsformater

@article{720b5f482a844a46af7bc395c99c3cc9,

title = "Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions",

abstract = "Montelukast is a potent leukotriene-receptor antagonist administered once daily that provides clinical benefit in the treatment of asthma and allergic rhinitis in children and adults. Because of its wide use as a pediatric controller, there is a need for a further review of the safety and tolerability of montelukast in children.",

author = "Hans Bisgaard and David Skoner and Boza, {Maria L} and Tozzi, {Carol A} and Kathleen Newcomb and Reiss, {Theodore F} and Barbara Knorr and Gertrude Noonan",

year = "2009",

month = jun,

day = "1",

doi = "10.1002/ppul.21018",

language = "English",

volume = "44",

pages = "568--79",

journal = "Pediatric Pulmonology",

issn = "8755-6863",

publisher = "John Wiley and Sons Inc.",

number = "6",

}

TY - JOUR

T1 - Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions

AU - Bisgaard, Hans

AU - Skoner, David

AU - Boza, Maria L

AU - Tozzi, Carol A

AU - Newcomb, Kathleen

AU - Reiss, Theodore F

AU - Knorr, Barbara

AU - Noonan, Gertrude

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Montelukast is a potent leukotriene-receptor antagonist administered once daily that provides clinical benefit in the treatment of asthma and allergic rhinitis in children and adults. Because of its wide use as a pediatric controller, there is a need for a further review of the safety and tolerability of montelukast in children.

AB - Montelukast is a potent leukotriene-receptor antagonist administered once daily that provides clinical benefit in the treatment of asthma and allergic rhinitis in children and adults. Because of its wide use as a pediatric controller, there is a need for a further review of the safety and tolerability of montelukast in children.

U2 - 10.1002/ppul.21018

DO - 10.1002/ppul.21018

M3 - Journal article

C2 - 19449366

SN - 8755-6863

VL - 44

SP - 568

EP - 579

JO - Pediatric Pulmonology

JF - Pediatric Pulmonology

IS - 6

ER -

Safety and tolerability of montelukast in placebo-controlled pediatric studies and their open-label extensions

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater